A review of molecular genetic studies of neurocognitive deficits in schizophrenia

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

卷:72

Review

Zai, Gwyneth^1,2,3,4,5  Robbins, Trevor W.^4,6  Sahakian, Barbara J.^4,5  Kennedy, James L.^1,2,3 

[1] Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON, Canada

[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada

[3] Univ Toronto, Inst Med Sci, Toronto, ON, Canada

[4] Univ Cambridge, MRC Wellcome Trust Behav & Clin Neuroscie Inst, Cambridge, England

[5] Univ Cambridge, Dept Psychiat, Cambridge, England

[6] Univ Cambridge, Dept Psychol, Cambridge, England

关键词: Genetics;    Schizophrenia;    Neurocognition;    Cognitive deficits;    Candidate gene studies;    Genome-wide association studies (GWASs);   

DOI  :  10.1016/j.neubiorev.2016.10.024

来源: Elsevier

【 摘 要 】

Schizophrenia is a complex and debilitating illness with strong genetic loading. In line with its heterogeneous symptomatology, evidence suggests genetic etiologies for the phenotypes in schizophrenia. A search across endophenotypes has pointed towards consistent findings in its neurocognitive deficits. Extensive literature has demonstrated impaired cognition including executive function, attention, and memory in schizophrenia patients when compared to healthy subjects. This review (1) provides an overview of recent studies and (2) develops an up-to-date conceptualization of genetic variations influencing neurocognitive functions in schizophrenia patients. Several neurotransmitter system genes have been examined given knowledge of their role in brain functions and their reported genetic associations with schizophrenia and cognition. Several genetic variations have emerged as having preliminary effects on neurocognitive deficits in schizophrenia. These include genes in the neurotrophic, serotonin, cell adhesion, and sodium channel systems. Limited evidence also suggests the dopaminergic system genes, with the most studied catechol-o-methytransferase (COMT) gene showing inconsistent findings. Further investigations with larger samples and replications are required to elucidate genetic risk for cognitive deficits in schizophrenia. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.

【 授权许可】

Free